Medpace Holdings, Inc.

NASDAQ:MEDP

Medical - Diagnostics & Research

Healthcare
$646.87 -0.98%

-$4.51 today

Market cap
$18.09B
Beta
1.18
P/E (TTM)
28.2
EPS (TTM)
$16.19
52W Low $301.90High $628.92

Volume 0.21M

Average 0.36M

MEDP Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Medpace Holdings, Inc.NASDAQ: MEDP

Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026

Stock-based compensation growth accelerates

Q3 FY2026 stock-based compensation of $7.6M rose 20.3% year over year, ahead of the -35.8% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 74.9% from the prior quarter. Over 3 fiscal years it compounded at +17.6% a year.

Context

  • Stock-based compensation amounted to 1.4% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +20.3% holds above the trailing-twelve-month pace of -35.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$7.6M+74.9% QoQ
Last fiscal yearDec 2025
$34.79M+36.3% YoY
LTMSep 2026
$22.49M-35.8% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.3%——
1 year+36.3%——
3-year CAGR+17.6%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
34.79M USD
Year-over-year change
+36.3%
4-year CAGR
+24.5%

Stock-Based Compensation vs competitors

How MEDP compares with its peers on the latest reported figures

  • MEDP's LTM Sep 2026 stock-based compensation of $22.49M is the smallest of the 5 companies compared; the peer median is $121.43M.
  • Its year-over-year change of -35.8% is the lowest of 5, against a peer median of +19.5%.
  • Stock-based compensation amounts to 0.8% of revenue for MEDP, versus a peer median of 1.9%.
MEDP Competitors Peer median
Stock-Based Compensation for MEDP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$275M +17.5%+8.4%1.6%
ICLRICON Public Limited CompanyLTM Jun 2026$177.43M +291.4%+13.1%2.1%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$65.43M -2.0%-1.2%1.6%
FTREFortrea Holdings Inc.LTM Jun 2026$61.1M +21.5%+43.1%2.3%
MEDPMedpace Holdings, Inc.LTM Sep 2026$22.49M -35.8%+17.6%0.8%
Peer median (excluding MEDP) $121.43M+19.5%+10.7%1.9%

Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income181.85M245.37M282.81M404.39M451.12M
Depreciation & Amortization21.12M22.34M26.33M29.25M28.12M
Deferred Income Tax(37.11M)(23.01M)(25.12M)(26.63M)80.77M
Stock-Based Compensation14.47M21.41M20.52M25.51M34.79M
Change in Working Capital66.71M106.06M106.49M157.18M96.28M
Accounts Receivables(24.98M)(66.92M)(48.28M)2.24M(106.22M)
Inventory00000
Accounts Payables1.87M6.43M1.05M(2.97M)2.63M
Other Working Capital89.82M166.54M153.72M157.9M199.86M
Other Non-Cash Items16.3M15.89M22.35M19.12M22.14M
Operating Cash Flow263.33M388.05M433.37M608.82M713.22M
Capital Expenditures(28.27M)(36.88M)(36.65M)(36.55M)(31.36M)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.09M)(1.86M)2.02M8.24M216K
Investing Cash Flow(31.36M)(38.74M)(34.63M)(28.31M)(31.14M)
Debt Repayment050M(50M)00
Common Stock Issued000057M
Common Stock Repurchased(62.1M)(847.85M)(144.02M)(169.87M)(917.39M)
Dividends Paid00000
Other Financing Activities17.64M22.07M11.38M15.86M0
Financing Cash Flow(44.45M)(775.78M)(182.64M)(154.01M)(860.39M)
Effect of Forex Changes(3.97M)(6.57M)1.08M(2.51M)5.92M
Net Change in Cash183.54M(433.04M)217.18M423.99M(172.39M)
Free Cash Flow235.06M351.17M396.73M572.27M681.87M

Medpace Holdings, Inc.

NASDAQ:MEDP

Intrinsic Alpha fair value

Locked

Current Price

$646.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.